Skip to main content
Premium Trial:

Request an Annual Quote

Arcis Biotechnology, Teleflex Sign License Agreement

NEW YORK (GenomeWeb) – Arcis Biotechnology announced yesterday that it has signed a technology access agreement with Teleflex.

As part of the agreement, Teleflex will use Arcis' nucleic acid sample preparation chemistry to develop a rapid diagnostic assay using RNA detection. Arcis' two-step nucleic acid extraction and preservation technology enables earlier, more accurate diagnostic testing from a variety of sample types, the company said.

This partnership comes after Arcis' announcement earlier this month that it had raised £1.3 million ($1.7 million) in an investment round. The firm now plans to invest further in research and development, product development, and international business expansion.

The Scan

Less Than Half

An effort to reproduce key findings from high-profile preclinical cancer studies finds less than half could be replicated, according to the Scientist.

Still Some SARS-CoV-2 Sequencing Holes

The Wall Street Journal reports that viral genomic surveillance has improved in the US, though says there are still gaps.

Avoiding Passing Them On

People with known disease-linked genetic variants are turning to in vitro fertilization so as to not pass those variants to their children, the Washington Post says.

PNAS Papers on Long Cell-Free DNA in Maternal Plasma, Genetic Propensity for Voting

In PNAS this week: long, cell-free DNA of maternal and fetal origins identified in maternal plasma, and more.